Background: Antidepressant drugs such as fl uoxetine are of the most commonly used drugs among the public. These drugs may impact the regulation of bone cell functioning, and thus affect orthodontic tooth movement. The aim of this study was to determine the effect of fl uoxetine on tooth movements during orthodontic treatment in rats. Materials and Methods: In this study, 30 male rats were randomly assigned into two groups and injected with fl uoxetine 10 mg/kg (experimental group) and normal saline (control group) for a period of 1-month intraperitoneally 5 times/week. Then, the rats were anesthetized and a nickeltitanium closed-coil spring was placed between the left maxillary fi rst molar and left maxillary central incisors of all samples, and then fl uoxetine (experimental group) and normal saline (control group) were injected for another 3 weeks by the same method. After measuring tooth movements, rats were sacrifi ced, and histomorphometric analyses were conducted and the obtained data were statistically analyzed using independent t-test and the signifi cance was set at 0.05. Results: Following the fl uoxetine injection, the mean amount of tooth movements in the experimental group was reduced compared to the control group, which was not statistically signifi cant (P = 0.14). There was no signifi cant difference between the two groups regarding bone apposition rate (P = 0.83), external root resorption rate (P = 0.1), and mean number of root resorption lacunae (P = 0.16). Conclusion: Within the limitations of this study, systemic use of fl uoxetine may cause insignifi cant reduction of tooth movement rate in rats; however, this subject needs more evaluations.
INTRODUCTION
Orthodontic treatment includes controlled force application onto the teeth and their surrounding structures. [1] After applying orthodontic forces, the periodontium goes out of balance; on the resorption side, osteoclast precursors move to the bone surface and differentiate. At the same time, osteoblasts that are derived from local cells form the bone on the tension side and start the process of remodeling in the resorbed areas in the pressure side. [2] Prostaglandin E has an important role in the cascade of signals related to tooth movement, and it seems that its inhibitors also affect the tooth movement. Several drug classes, such as tricyclic antidepression drugs, can affect prostaglandins and the orthodontic force responses. [2] On the other hand, given the increasing rate of depression among adolescents and young adults in Iran and the world which results in the consumption of antidepressants, the signifi cance of these drugs has increased. [3] Accordingly, it is likely that a considerable percentage of those who are candidates for orthodontic treatment may be consuming these types of drugs to treat their depression. Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class, which can treat disorders such as depression, anxiety, and obsession. This drug can have an important role in bone regulation in growing individuals because it remains for a long time in bone marrow after complete elimination from plasma and brain. [4] In studying the effects of several antidepressant drugs such as fl uoxetine, it was discovered that this drug has destructive effects on both trabecular and cortical bones. [5] Furthermore, it was determined that peripheral serotonin produced by the intestinal cells lead to a decrease in osteoblast proliferation and can affect the bone density. [6] Branco-de-Almeida et al. [7] evaluated the anti-infl ammatory effects of fl uoxetine on lab rats and showed that fl uoxetine reduces the infl ammatory response and prevents the bone loss, and it may be benefi cial in treating periodontal diseases. Furthermore, Mortazavi et al. [8] found that fl uoxetine can improve the level of bone regeneration in calvarial bone lesions.
Finally, considering that the effects of antidepressant drugs on the bones have been proven, but the effects of these drugs on alveolar bone and following tooth movement have not been studied, and also the high prevalence of antidepressant drugs' consumption, especially fl uoxetine, in the Iranian society, [3] in this study, we attempted to investigate the effect of fl uoxetine on tooth movements and alveolar bone in lab rats.
MATERIALS AND METHODS
This experimental animal study was performed on 30 male rats between the ages of 8 and 10 weeks (beginning of rats' sexual maturation). The rats were randomly divided into two groups of experimental and control (15 rats in each group). Given the maximum variance equal to α = 0.05 unit, the required number of rats for both groups was 27, which 30 rats (15 in each group) were collected and sampling was conducted in the animals' convenience form.
The experimental group rats were intraperitoneally injected with 10 mg/kg fl uoxetine [9] (Abidi Pharmacy, Iran) 5 times/week and the control group rats were injected with normal saline in the same method. After 1-month, the rats were anesthetized using 20 mg/kg ketamine hydrochloride 10% (Dork Davis, France). The distance between the maxillary central incisor's incisal edge and the mesiobuccal cusp of the upper fi rst molar on the left side was measured using a digital caliper [10] (1108-150, Insize Co., China). Then, the fi rst molar and left maxillary central incisor were perforated using a fi ssure bur (fl at end cylinder 835, Teeskavan, Iran) and a 0.01 inch ligature wire (Ligature Ties 0.01, Orthotechnology, USA) which a nickel-titanium closedcoil spring (close coil spring with eyelets, size 9F, G & H wire Co., USA) had gone through it, was tied around the fi rst molar and maxillary central incisor, so that a 50 g load could be applied in the desired area After that, the drug injection was continued for another 3 weeks by the same method.
Due to the diffi culty of maintaining the coil spring inside the rat's oral cavity, the drug was injected fi rst and after 1-month the appliance was placed. Regarding the continuous eruption of rat's mandibular incisors which cause attrition in maxillary incisors, the coil spring would have become detached if maintained for a long time. According to similar studies, 3 weeks was enough for inducing tooth movement. [11] However, 6 weeks is necessary for evaluating the fl uoxetine effect on the bone structure. [9] After 3 weeks, the rats were anesthetized, and the distance between the incisor and maxillary molar was measured with a digital caliper again. The tooth movements throughout the 21 days were calculated and then the rats were sacrifi ced, decapitated, placed in 10% formalin (Merck, Germany) and were sent to the laboratory. In the laboratory, samples were prepared from the maxillary fi rst molar along with the adjacent bone. Samples were then stabilized in buffered 10% formalin (Merck, Germany) for 24 h and after that, they were kept in acid for 24 h, and the preparation steps were conducted.
Tissues were sectioned longitudinally from the mesiobuccal root and the adjacent bone (serial section with 4-5 micron thickness), by using a microtome (Leica, RM 2035, Germany). The sections were placed on slides and stained with trichromasson stain (Merk, Germany) for identifying bone formation [ Figures 1 and 2 ].
The number of root resorption lacunae was calculated in 5 nonoverlaping high power fi elds by light microscope (Olympus BX-51, Japan) with magnifi cation ×400 by an oral pathologist twice and with a time interval of 4 weeks.
The percentage of bone apposition was calculated histomorphologically using Nilu software (Nilu pathology image analyzer, Iran). This software is based on different color identification. In Trichrome Masson staining, bone formation is colored as blue and histomorphologically, in ×100 magnification, the percentage of bone formation was calculated.
Root resorption rate was measured using the described software (Nilu pathology image analyzer, Iran). For this purpose, the surface area of the whole root and the surface area of the root resorption lacunae were measured in each cross section. Using the following formula, the percentage of root resorption area was calculated.
All measurements were performed by a pathologist 2 times and with a time interval of 4 weeks.
Finally, the mean values for the two experimental and control groups were analyzed through the independent t-test and SPSS version 18 (SPSS Inc., Chicago, IL, USA) was used for data analysis. The signifi cance was set at 0.05.
RESULTS
In this study, the following results were obtained:
• The mean tooth movements for the experimental group samples was 1.5 ± 0.76 mm and for the control group was 2.07 ± 0.49 mm, which indicates that the level of tooth movements was reduced subsequent to the injection of fl uoxetine, but this was not statistically signifi cant (P = 0.14)
[ Table 1 ].
• The mean bone apposition rate was 7.02% ± 4.05% in the control group and 6.52% ± 3.91% for the experimental group, which showed that there was no signifi cant difference between two groups regarding bone mineral apposition rates (P = 0.83) [ Table 1 ].
• The mean external root resorption was 0.49% ± 0.36% in the control group and 0.14% ± 0.35% in the experimental group that revealed that there was no signifi cant difference between the two groups regarding the external root resorption rates (P = 0.1) [ Table 1 ].
• The mean number of root resorption lacunae in control group samples was 1.57 ± 0.98 and in the experimental group was 1.21 ± 0.67, which shows that there was no signifi cant difference (P = 0.16) [ Table 1 ].
DISCUSSION
In this research, we investigated how fl uoxetine effects the amount of tooth movements and root resorption during the tooth movements. In this study, we concluded that tooth movement rate was reduced after fl uoxetine injection.
The reason for selecting fl uoxetine in this study was a high prevalence of its consumption in the society. Although there are many studies which have evaluated the effect of antidepressant drugs on bone formation and bone density, no study has yet evaluated the effects of these drugs on the amount of tooth movement.
Applying orthodontic forces on the pressure side, cytokines such as prostaglandin E2 and interleukin 1 and 6 and also tumor necrosis factor-α are released from the periodontal ligament cells, which leads to infl ammation and increase of receptor activator of nuclear factor kappa-B ligand and followed by that the osteoclasts are activated and cause bone loss in the pressure side and cause tooth movements. [12] If this infl ammatory process could be reduced in the pressure side, tooth movement could be decreased.
Many studies have evaluated the anti-infl ammatory effect of fl uoxetine. Waiskopf et al. [13] showed the anti-infl ammatory effects of fl uoxetine. Branco-deAlmeida et al. [7] also showed the anti-infl ammatory effects of this drug on lab rats. Furthermore, Alboni et al. [14] revealed the anti-infl ammatory effects of long-term consumption of fl uoxetine and imipramine on the hypothalamus of rat. Thus, the reduction of tooth movements in the present study is associated with the anti-infl ammatory effects of fl uoxetine. However, the drug's effect on the osteoblasts and osteoclasts can also be considered.
In depression, the brain's serotonin level decreases. Fluoxetine occupies the serotonin receptors; therefore, its reuptake is reduced which leads to higher serotonin levels. Serotonin has various receptors in the peripheral organs. Osteoclast and osteoblast also have serotonin receptors and the effect of fl uoxetine on bone cells is through these receptors.
Contradictory results have been reported regarding the effects of fl uoxetine on the increase in resorption and apposition. Battaglino et al. [9] showed that systematically prescribing fl uoxetine leads to an increase of trabecular and a decrease of the trabecular space in the bone. Mortazavi et al. [8] also showed the increase of ossifi cation when using fl uoxetine in the calvarial lesions of lab rats. Gustafsson et al. [15] also showed positive effects of serotonin on increasing ossifi cation and decreasing bone loss in lab rats, which the results of these studies correspond to the reduction of tooth movements obtained in the present study. Fluoxetine does not always cause an increase in the osteoblast activity. Some studies have reported an increasing risk of osteoporosis in patients who consume this drug, which shows an increase in osteoclast activity. [5, [16] [17] [18] Bonnet et al. [5] showed a reduction in bone strength and a reduction of minerals in the femur of rats after consuming fl uoxetine. Warden et al. [17] confi rmed the anti-anabolic effects of fl uoxetine and the anabolic effects of lithium behavior stabilizing antidepressant drugs. Shea et al. [18] observed more bone loss after using SSRI drugs. Diem et al. [16] and Richards et al. [12] showed that antidepressant drugs lead to an increase in clinical fractures. The results of these studies do not agree with the reduction of tooth movements observed in the present study. Maybe if another antidepressant drug was used instead of fl uoxetine, the reduction in tooth movements would be more evident. Because these drugs in addition to their anti-infl ammatory properties, which is also seen in fl uoxetine, have positive effects on bone mineral density and bone anabolic properties. However, in the case of fl uoxetine, the results were contradictory. As it has been shown in two previous studies, [8, 19] ossifi cation rate is highly dependent on the dose, if fl uoxetine was used in different doses, different results would be obtained.
In the microscopic evaluation, the level of ossifi cation adjacent to the mesiobuccal root of the maxillary fi rst molar was investigated, which was used to determine the effect of fl uoxetine on the mineralization during alveolar bone remodeling. The lower amount of bone apposition observed in the experimental group could be associated with the ability of fl uoxetine in preventing human mesenchymal stem cells and preosteoblast. This fi nding agrees with the results of Bonnet et al., [5] Warden et al. [17] and Richards et al. [12] which indicated that fl uoxetine consumption reduces bone mineral density and increases the rate of bone fracture.
The external root resorption rate and mean number of root resorption lacunae in the experimental and control groups showed a reduction in the root resorption rate in the experimental group, yet the amount of this reduction was not signifi cant. The minor root resorption reduction in the experimental group can be related to fl uoxetine's anti-infl ammatory effects. Infl ammation activates osteoclasts which as a side effect can cause root resorption during orthodontic movements, [1] and this fi nding agrees with the results of Reitan [20] that stated lateral root resorption during orthodontic tooth movements is common.
There is also a relationship between bone density and root resorption. Teeth that are moved close to the dense cortical bone show more root resorption compared to cases where the tooth is moved in the trabecular bone. [21] In this study, due to the effect of the fl uoxetine injection, the bone's mineral apposition rate was reduced. The lower amount of root resorption observed in the experimental group, in addition to the anti-infl ammatory effects of the drug, was due to this less bone density. Finally, the reduced mineral apposition rate of the experimental group compared to the control group confi rms the drugs ability to reduce osteoblastic activity and increase osteoclastic activity. Therefore, the less tooth movement in the experimental group is due to the drug's antiinfl ammatory function, which can be the cause for less root resorption in the experimental group.
It should be mentioned that the results of animal studies cannot be always extended to humans because the dose, duration of force prescription, bone structure, and force level are not the same between human and rat.
CONCLUSION
Within limitations of this study, systemic use of fl uoxetine can cause insignifi cant reduction of tooth movement rate in rats; however, this subject needs more clarifi cation by future research.
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